Revolutionizing Eye Care
OIS Podcast | Ophthalmology's leading Podcast
English - June 07, 2024 22:00 - 41 minutes - 28.5 MB - ★★★★★ - 30 ratingsInvesting Business Health & Fitness ophthalmology investment venture capital entrepreneurs oftalmólogo ophthalmic key opinion leader seco ascrs aao Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Todays Therapies are Not Sufficient: A Marketplace Ripe for Innovation
Next Episode: Advances in Corneal Health
In our latest episode, host Dr. Rob Rothman interviews Greg Kunst, CEO of Aurion Biotech, to delve into the forefront of cell therapy for corneal disease. Join us to discover:
Greg's journey from pivotal roles at Alcon and Glaukos to leading Aurion BiotechThe innovative allogenic cell therapy technology developed by AurionHow this technology addresses the global shortage of corneal tissueInsights into the challenges and breakthroughs in scaling production and securing market approvalFuture applications of cell therapy in ophthalmology beyond corneal endothelial diseaseDon't miss this fascinating conversation on the future of medical innovation in ophthalmology! Listen to the episode and subscribe to the OIS Podcast for more updates on the latest trends in eye care and medical technology.